- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05412797
Use of a DeskCycle to Reduce Sedentary Behavior During the Workday
June 7, 2022 updated by: Melissa Zullo, Kent State University
The purpose of this research was to evaluate the effectiveness of a DeskCycle intervention in reducing sedentary behavior by increasing the time spent participating in light to moderate physical activity in a randomly selected group of desk job employees at Kent State University main campus.
The study also assessed the feasibility of using the DeskCycle in the working environment, as well as the effect on weight and mood.
The primary outcome of interest was the 'mean minutes of light to moderate physical activity'.
Secondary outcomes include weight, mood score, and feasibility of using the DeskCycle.
The study was a randomized controlled trial (RCT) with a cross-over design where differences between the intervention and control group were evaluated over an eight-week period, after which there was a switch and the DeskCycles were given to the control group to use for the eight-week period that followed.
The allocation during the first eight-week period intervention will be done through random process.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
80
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ohio
-
Kent, Ohio, United States, 44242
- Kent State University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
14 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- females 18 years and above
- full-time Kent State university administrative employees at the Kent main campus
- sedentary for 75% of their workday
- height under 5'10"
- desk height of at least 27"
Exclusion Criteria:
- any uncontrolled cardiovascular diseases
- back, knee or other joint pains
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Cycling
Used a DeskCycle during the workday/the intervention increased the amount of time spent being physically active.
|
The intervention was conducted in two phases.
In phase 1, the intervention group were given the DeskCycles to use for 8 weeks.
In phase, the control group from phase 1 were given the DeskCycles to use.
Intervention group from phase 1 became controls in phase 2
|
|
Active Comparator: Control
Regular activities
|
The active comparator performed normal daily activities
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Minutes of Exercise
Time Frame: Daily (M-F) for 8 weeks time period 1 and 2
|
Mean minutes of light to moderate physical activity
|
Daily (M-F) for 8 weeks time period 1 and 2
|
|
Feasibility of using the deskcycle during work
Time Frame: Week 2 period 1 and 2
|
How feasible was it to use the DeskCycle during work
|
Week 2 period 1 and 2
|
|
Feasibility of using the deskcycle during work
Time Frame: Week 8 period 1 and 2
|
How feasible was it to use the DeskCycle during work
|
Week 8 period 1 and 2
|
|
Mood
Time Frame: Baseline period 1 and 2
|
How was mood impacted during the work day
|
Baseline period 1 and 2
|
|
Mood
Time Frame: Week 4 period 1 and 2
|
How was mood impacted during the work day
|
Week 4 period 1 and 2
|
|
Mood
Time Frame: Week 8 period 1 and 2
|
How was mood impacted during the work day
|
Week 8 period 1 and 2
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in weight
Time Frame: Baseline to end of study period 1 and 2
|
Bodyweight before and after the study
|
Baseline to end of study period 1 and 2
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 1, 2017
Primary Completion (Actual)
April 6, 2018
Study Completion (Actual)
May 6, 2018
Study Registration Dates
First Submitted
May 4, 2022
First Submitted That Met QC Criteria
June 7, 2022
First Posted (Actual)
June 9, 2022
Study Record Updates
Last Update Posted (Actual)
June 9, 2022
Last Update Submitted That Met QC Criteria
June 7, 2022
Last Verified
June 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 17-226
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Disease
-
3-C Institute for Social DevelopmentUniversity of North Carolina, Chapel HillCompletedChronic Kidney Diseases | Chronic Kidney Disease Stage 5 | Chronic Kidney Disease stage4 | Pediatric Kidney Disease | Chronic Kidney Disease stage3 | Chronic Kidney Disease Stage V | Chronic Kidney Disease, Stage IV (Severe) | Chronic Kidney Disease Stage 2 | Chronic Kidney Disease, Stage IUnited States
-
Universiti Putra MalaysiaRecruitingChronic Kidney Diseases | Chronic Kidney Disease Stage 5 | Chronic Kidney Disease stage4 | Chronic Kidney Disease stage3 | Chronic Kidney Disease Requiring Chronic DialysisMalaysia
-
Parker Research InstituteOak Foundation; Rehabilitation Center Rødovre Municipality (Genoptræning Rødovre... and other collaboratorsRecruitingChronic Disease | Chronic Conditions, Multiple | Chronic ConditionDenmark
-
Parker Research InstituteOak Foundation; Rehabilitation Center Rødovre Municipality (Genoptræning Rødovre... and other collaboratorsCompletedChronic Conditions, Multiple | Chronic ConditionDenmark
-
Radboud University Medical CenterCompleted
-
Radboud University Medical CenterRecruitingChronic Conditions, Multiple | Chronic ConditionNetherlands
-
University of LimerickCompletedChronic Conditions, MultipleIreland
-
University of LeicesterUniversity Hospitals, Leicester; University of StrathclydeRecruitingChronic Obstructive Pulmonary Disease (COPD) | Chronic Obstructive Lung Disease | Chronic Obstructive Airway DiseaseUnited Kingdom
-
National Taipei University of Nursing and Health...TerminatedChronic Pulmonary Disease | Chronic Obstructive Pulmonary Disease Exacerbation | Chronic Obstructive Pulmonary Disease With ExacerbationTaiwan
-
National Taiwan University HospitalCompletedChronic Kidney Disease stage4 | Chronic Kidney Disease stage3 | Chronic Kidney Disease Stage 2 | Chronic Kidney Disease Stage 1Taiwan
Clinical Trials on Cycling/Using a DeskCycle
-
University of British ColumbiaCompletedEndothelial Dysfunction | Endothelial Function | Cardiovascular Physiological PhenomenaCanada
-
Kutahya Health Sciences UniversityCompletedQuality of Life | Fatigue | Coronary Heart Disease | Functional CapacityTurkey
-
University of SydneyCompleted
-
Ataturk UniversityCompletedCesarean Section; Dehiscence | First BirthTurkey
-
Hospices Civils de LyonCompletedCovid19 | Respiratory Distress Syndrome | Ventilators, MechanicalFrance
-
Joslin Diabetes CenterCompletedHypoglycemia | Physical Activity | Roux-en-Y Gastric Bypass | Post-bariatric HypoglycemiaUnited States
-
Eda SORKUNCompleted
-
University Hospital, BordeauxCompletedHeart Failure | Coronary Disease | Cardiomyopathy, DilatedFrance
-
Ankara Yildirim Beyazıt UniversityRecruitingHypersensitivity | Molar Incisor HypomineralizationTurkey (Türkiye)
-
The Leeds Teaching Hospitals NHS TrustUnknown